Progressive neurological disease induced by tacrolimus in a renal transplant recipient: Case presentation

被引:21
|
作者
Chegounchi M. [1 ]
Hanna M.G. [2 ]
Neild G.H. [1 ]
机构
[1] Department of Nephrology, UCL Hospitals Trust, Middlesex Hospital, W1T 3AA, London
[2] Department of Neurology, UCL Hospitals Trust, Middlesex Hospital, W1T 3AA, London
关键词
Tacrolimus; Calcineurin Inhibitor; Tacrolimus Concentration; Slur Speech; Hypertensive Encephalopathy;
D O I
10.1186/1471-2369-7-7
中图分类号
学科分类号
摘要
Background: Tacrolimus and cyclosporine, both calcineurin inhibitors, can cause neurological side effects. While mild symptoms such as tremor are well recognised, severe complications including seizures and encephalopathy are poorly documented following renal transplantation. Case presentation: We report a 42 year old man who received a cadaver renal transplant. He received tacrolimus and prednisolone. The course was uneventful for 6 weeks when he became intermittently confused, with unsteady gait and slurred speech. Following a grand mal convulsion he was admitted. He had no focal neurological signs, cerebrospinal fluid was normal; electroencephalogram was consistent with temporal lobe partial epilepsy. The magnetic resonance imaging of brain showed widespread changes with multiple areas of low signal intensity in brain stem and cerebral hemispheres. He was readmitted 3 weeks later after further fits, despite anti-convulsant therapy. He was psychotic with visual hallucinations, and rapidly became obtunded. Although his tacrolimus blood concentration had been kept in the normal range, his symptoms improved dramatically when the tacrolimus was stopped. Conclusion: Severe central nervous system toxicity from calcineurin inhibitors has been rarely reported in renal transplantation and we found only one report of tacrolimus-induced toxicity in an adult. We believe the condition is frequently undiagnosed. It is a very important diagnosis not to miss as the remedy is simple and failure may result in unnecessary brain biopsy, as well as irreversible injury. © 2006Chegounchi et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 50 条
  • [1] A Case Report of a Renal Transplant Patient with Progressive Neurological Disorder due to Tacrolimus
    Sagiroglu, Tamer
    Meydan, Burhan
    EURASIAN JOURNAL OF MEDICINE, 2009, 41 (03): : 200 - 201
  • [2] Tacrolimus-induced hemolytic uremic syndrome case presentation in a lung transplant recipient
    Shitrit, D
    Starobin, D
    Aravot, D
    Fink, G
    Izbicki, G
    Kramer, M
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (02) : 627 - 628
  • [3] Tacrolimus-Induced Cardiomyopathy in an Adult Renal Transplant Recipient
    Bowman, Lyndsey J.
    Brennan, Daniel C.
    Delos-Santos, Rowena
    LaRue, Shane J.
    Anwar, Siddiq
    Klein, Christina L.
    PHARMACOTHERAPY, 2015, 35 (12): : 1109 - 1116
  • [4] A COMPLEX CASE OF PROGRESSIVE PNEUMONIA IN A RENAL TRANSPLANT RECIPIENT
    Viggiano, Taylor
    CHEST, 2024, 166 (04) : 1563A - 1563A
  • [5] COLCHICINE INDUCED MYOPATHY IN A TACROLIMUS-TREATED RENAL TRANSPLANT RECIPIENT
    Reddy, Samitha
    Bhat, Zeenat
    Doshi, Mona
    Wilpula, Elizebeth
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (04) : A82 - A82
  • [6] Gangliocytoma Presenting With Tacrolimus Neurotoxicity in a Renal Transplant Recipient: Case Report
    Alagoz, S.
    Gulcicek, S.
    Oruc, M.
    Trabulus, S.
    Seyahi, N.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (09) : 3142 - 3144
  • [7] Interaction between Tacrolimus and Theophylline in a Renal Transplant Recipient: A Case Report
    Gaies, Emna
    Trabelsi, Sameh
    Salouage, Issam
    Jebabli, Nadia
    Charfi, Rim
    Lakhal, Mohamed
    Klouz, Anis
    THERAPIE, 2011, 66 (06): : 553 - 554
  • [8] Role of Fludrocortisone in the Management of Tacrolimus-Induced Hyperkalemia in a Renal Transplant Recipient
    Sivakumar, V.
    Sriramnaveen, P.
    Krishna, C.
    Manjusha, Y.
    Reddy, Y. Sandeep
    Sridhar, N.
    Subramanian, S.
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2014, 25 (01) : 149 - 151
  • [9] COELIAC DISEASE SECONDARY TO TACROLIMUS IN KIDNEY TRANSPLANT RECIPIENT: CASE REPORT
    Sahtout, Wissal
    Ben Aicha, Narjes
    Azzabi, Awatef
    Guedri, Yosra
    Mrabet, Sanda
    Nouira, Safa
    Sabri, Ferdawes
    Ben Amor, Samira
    Yacoub, Nadra
    Ben Halima, Hichem
    Zallama, Dorsaf
    Achour, Abdellatif
    TRANSPLANT INTERNATIONAL, 2015, 28 : 732 - 732
  • [10] Rescue therapy with sirolimus in a renal transplant recipient with tacrolimus-induced hepatotoxicity
    Mesar, Ines
    Kes, Petar
    Hudolin, Tvrtko
    Basic-Jukic, Nikolina
    RENAL FAILURE, 2013, 35 (10) : 1434 - 1435